Literature DB >> 16239610

Serum erythropoietin levels in healthy humans after a short period of normobaric and hyperbaric oxygen breathing: the "normobaric oxygen paradox".

Costantino Balestra1, Peter Germonpré, Jacques R Poortmans, Alessandro Marroni.   

Abstract

Renal (peritubular) tissue hypoxia is a well-known physiological trigger for erythropoietin (EPO) production. We investigated the effect of rebound relative hypoxia after hyperoxia obtained under normo- and hyperbaric oxygen breathing conditions. A group of 16 healthy volunteers were investigated before and after a period of breathing 100% normobaric oxygen for 2 h and a period of breathing 100% oxygen at 2.5 ATA for 90 min (hyperbaric oxygen). Serum EPO concentration was measured using a radioimmunoassay at various time points during 24-36 h. A 60% increase (P < 0.001) in serum EPO was observed 36 h after normobaric oxygen. In contrast, a 53% decrease in serum EPO was observed at 24 h after hyperbaric oxygen. Those changes were not related to the circadian rhythm of serum EPO of the subjects. These results indicate that a sudden and sustained decrease in tissue oxygen tension, even above hypoxia thresholds (e.g., after a period of normobaric oxygen breathing), may act as a trigger for EPO serum level. This EPO trigger, the "normobaric oxygen paradox," does not appear to be present after hyperbaric oxygen breathing.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16239610     DOI: 10.1152/japplphysiol.00964.2005

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  21 in total

1.  Hypoxia, a multifaceted phenomenon: the example of the "normobaric oxygen paradox".

Authors:  C Balestra; P Germonpré
Journal:  Eur J Appl Physiol       Date:  2012-03-31       Impact factor: 3.078

2.  Prevailing evidence contradicts the notion of a "normobaric oxygen paradox".

Authors:  Michail E Keramidas; Ola Eiken; Igor B Mekjavic
Journal:  Eur J Appl Physiol       Date:  2012-03-31       Impact factor: 3.078

3.  EPO and doping.

Authors:  Costantino Balestra; Peter Germonpré
Journal:  Eur J Appl Physiol       Date:  2010-03-14       Impact factor: 3.078

4.  Repeated apnea-induced contraction of the spleen in cyclists does not enhance performance in a subsequent time-trial.

Authors:  Billy Sperlich; Christoph Zinner; Roman Pfister; Hans-Christer Holmberg; Guido Michels
Journal:  Eur J Appl Physiol       Date:  2014-09-27       Impact factor: 3.078

5.  A breath of fresh air for umbilical cord blood.

Authors:  Shannon L McKinney-Freeman
Journal:  Blood       Date:  2016-12-22       Impact factor: 22.113

6.  Acute short-term hyperoxia followed by mild hypoxia does not increase EPO production: resolving the "normobaric oxygen paradox".

Authors:  Tadej Debevec; Michail E Keramidas; Barbara Norman; Thomas Gustafsson; Ola Eiken; Igor B Mekjavic
Journal:  Eur J Appl Physiol       Date:  2011-07-07       Impact factor: 3.078

7.  Dark chocolate reduces endothelial dysfunction after successive breath-hold dives in cool water.

Authors:  Sigrid Theunissen; Julie Schumacker; François Guerrero; Frauke Tillmans; Antoine Boutros; Kate Lambrechts; Aleksandra Mazur; Massimo Pieri; Peter Germonpré; Costantino Balestra
Journal:  Eur J Appl Physiol       Date:  2013-12       Impact factor: 3.078

8.  Erythropoietin modulation is associated with improved homing and engraftment after umbilical cord blood transplantation.

Authors:  Omar S Aljitawi; Soumen Paul; Avishek Ganguly; Tara L Lin; Sid Ganguly; George Vielhauer; Maegan L Capitano; Amy Cantilena; Brea Lipe; Jonathan D Mahnken; Amanda Wise; Abigale Berry; Anurag K Singh; Leyla Shune; Christopher Lominska; Sunil Abhyankar; Dennis Allin; Mary Laughlin; Joseph P McGuirk; Hal E Broxmeyer
Journal:  Blood       Date:  2016-10-19       Impact factor: 22.113

9.  Increased erythropoietin concentration after repeated apneas in humans.

Authors:  Robert de Bruijn; Matt Richardson; Erika Schagatay
Journal:  Eur J Appl Physiol       Date:  2007-12-19       Impact factor: 3.078

10.  Sub-anesthetic Xenon Increases Erythropoietin Levels in Humans: A Randomized Controlled Trial.

Authors:  Christian Stoppe; Julia Ney; Martin Brenke; Andreas Goetzenich; Christoph Emontzpohl; Gereon Schälte; Oliver Grottke; Manfred Moeller; Rolf Rossaint; Mark Coburn
Journal:  Sports Med       Date:  2016-11       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.